Literature DB >> 24446456

Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.

Michael B Coulthart1, Gerard H Jansen2, Neil R Cashman2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24446456      PMCID： PMC4050025          DOI： 10.1503/cmaj.130720

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  44 in total

1.  Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.

Authors:  S Collins; A Boyd; A Fletcher; M Gonzales; C A McLean; K Byron; C L Masters
Journal:  J Clin Neurosci       Date:  2000-05       Impact factor: 1.961

2.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

3.  The threshold approach to clinical decision making.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1980-05-15       Impact factor: 91.245

Review 4.  The public health impact of prion diseases.

Authors:  Ermias D Belay; Lawrence B Schonberger
Journal:  Annu Rev Public Health       Date:  2005       Impact factor: 21.981

5.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

6.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  P Sanchez-Juan; A Green; A Ladogana; N Cuadrado-Corrales; R Sáanchez-Valle; E Mitrováa; K Stoeck; T Sklaviadis; J Kulczycki; K Hess; M Bodemer; D Slivarichová; A Saiz; M Calero; L Ingrosso; R Knight; A C J W Janssens; C M van Duijn; I Zerr
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

Review 7.  Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.

Authors:  B Van Everbroeck; J Boons; P Cras
Journal:  Clin Neurol Neurosurg       Date:  2005-01-12       Impact factor: 1.876

Review 8.  Biological and methodological features of the measurement of S100B, a putative marker of brain injury.

Authors:  Carlos-Alberto Gonçalves; Marina Concli Leite; Patrícia Nardin
Journal:  Clin Biochem       Date:  2008-04-18       Impact factor: 3.281

9.  Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  Peter Brechlin; Olaf Jahn; Petra Steinacker; Lukas Cepek; Hartmut Kratzin; Stefan Lehnert; Sarah Jesse; Brit Mollenhauer; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
Journal:  Proteomics       Date:  2008-10       Impact factor: 3.984

Review 10.  Rationale for diagnosing human prion disease.

Authors:  Gábor G Kovács; Till Voigtländer; Ellen Gelpi; Herbert Budka
Journal:  World J Biol Psychiatry       Date:  2004-04       Impact factor: 4.132
View more
  2 in total

1.  Creutzfeldt-Jakob disease: The search for definitive diagnostic tests continues.

Authors:  Michael B Coulthart; Beau M Ances
Journal:  Neurol Clin Pract       Date:  2015-04

2.  Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease.

Authors:  Keding Cheng; Robert Vendramelli; Angela Sloan; Brooks Waitt; Lisa Podhorodecki; Debra Godal; J David Knox
Journal:  J Clin Microbiol       Date:  2016-04-13       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.